Cancers is a peer-reviewed, open access journal of oncology published semimonthly online by MDPI. The Irish Association for Cancer Research (IACR), Signal Transduction Society (STS) and Spanish Association for Cancer Research (ASEICA) are affiliated with Cancers and their members receive a discount on the article processing charges.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and many other databases.
  • Journal Rank: JCR - Q1 (Oncology) / CiteScore - Q2 (Oncology)
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 17 days after submission; acceptance to publication is undertaken in 3.7 days (median values for papers published in this journal in the first half of 2021).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
  • Sections: published in 14 topical sections
  • Companion journals for Cancers include: Radiation and Onco.
Impact Factor: 6.639 (2020) ; 5-Year Impact Factor: 6.999 (2020)
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Biomedicines, Pharmaceutics, Pharmaceuticals, Cancers, Vaccines
Animal Model in Biomedical Research Editor-in-Chief: Marc Ekker
Deadline: 31 December 2021
Topic in Biology, Cancers
Application of Big Medical Data in Precision Medicine Editors-in-Chief: Yi Zhao, Jinpu Yu, Haifeng Zhang, Min Hu, Jincheng Guo
Deadline: 31 March 2022
Topic in Biomolecules, Cancers, Cells, Current Oncology
Advances in Ovarian Cancer Research: From Biology to Therapeutics Editor-in-Chief: Christina M. Annunziata
Deadline: 31 May 2022
Topic in Biomolecules, Cancers, Cells, Current Oncology, Onco
Adaptation Mechanisms in Therapy-Resistant Breast Cancer Deadline: 31 July 2022
Special Issue in Cancers
Nuclear Receptors and Cancer Guest Editors: Zeynep Madak-Erdogan, Matthew Sikora
Deadline: 15 December 2021
Special Issue in Cancers
Perioperative Interventions and Oncological Outcome in Surgical Cancer Patients Guest Editor: Donal J Buggy
Deadline: 31 December 2021
Special Issue in Cancers
Gammopathies of Certain Significance: Managing MGUS and Smoldering Myeloma Guest Editors: Maximilian Merz, Hartmut Goldschmidt
Deadline: 1 January 2022
Special Issue in Cancers
Nanoparticle-Based Combination Therapy and Diagnosis for Cancer Guest Editors: Elena Reddi, Francesca Moret
Deadline: 15 January 2022
Topical Collection in Cancers
Urological Cancer Collection Editor: José I. López
Topical Collection in Cancers
Drug Resistance and Novel Therapies in Cancers Collection Editor: Zhixiang Wang
Topical Collection in Cancers
The Role of Non-coding RNA in Cancer Collection Editor: Lyndsay Rhodes
Topical Collection in Cancers
Deciphering the Crosstalk between Tumor Cells and Their Microenvironment: From Molecular Aspects to Therapeutic Implications Collection Editors: Patrizia Limonta, Fabrizio Fontana
Back to TopTop